Bas van Vlijmen

725 total citations
14 papers, 557 citations indexed

About

Bas van Vlijmen is a scholar working on Family Practice, General Health Professions and Geriatrics and Gerontology. According to data from OpenAlex, Bas van Vlijmen has authored 14 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Family Practice, 4 papers in General Health Professions and 4 papers in Geriatrics and Gerontology. Recurrent topics in Bas van Vlijmen's work include Medication Adherence and Compliance (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Mobile Health and mHealth Applications (4 papers). Bas van Vlijmen is often cited by papers focused on Medication Adherence and Compliance (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Mobile Health and mHealth Applications (4 papers). Bas van Vlijmen collaborates with scholars based in Netherlands, United Kingdom and Spain. Bas van Vlijmen's co-authors include Marcel L. Bouvy, Liset van Dijk, D.H. de Bakker, Marcia Vervloet, Rune R. Frants, Hans van der Boom, Paul Krimpenfort, Arn M. J. M. van den Maagdenberg, Ino de Bruijn and Marten H. Hofker and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Journal of Medical Internet Research.

In The Last Decade

Bas van Vlijmen

14 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bas van Vlijmen Netherlands 7 186 153 98 93 83 14 557
Paula Anne Newman-Casey United States 26 155 0.8× 129 0.8× 77 0.8× 55 0.6× 103 1.2× 94 2.1k
Karen Van Nuys United States 10 56 0.3× 61 0.4× 47 0.5× 139 1.5× 27 0.3× 24 590
Shahnaz Khan United States 14 70 0.4× 63 0.4× 125 1.3× 155 1.7× 67 0.8× 30 816
Chanhyun Park United States 14 125 0.7× 26 0.2× 51 0.5× 102 1.1× 140 1.7× 68 684
So Jung Yang South Korea 9 190 1.0× 22 0.1× 28 0.3× 113 1.2× 31 0.4× 19 518
Bobby L. Clark United States 15 89 0.5× 40 0.3× 115 1.2× 23 0.2× 238 2.9× 27 886
Hua Feng United States 14 201 1.1× 13 0.1× 50 0.5× 117 1.3× 127 1.5× 17 955
Paul E. Knudson United States 10 200 1.1× 22 0.1× 98 1.0× 323 3.5× 99 1.2× 21 766
Lonneke Timmers Netherlands 13 80 0.4× 303 2.0× 13 0.1× 33 0.4× 30 0.4× 29 621
Eleanor Rivera United States 11 97 0.5× 17 0.1× 40 0.4× 33 0.4× 184 2.2× 26 700

Countries citing papers authored by Bas van Vlijmen

Since Specialization
Citations

This map shows the geographic impact of Bas van Vlijmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas van Vlijmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas van Vlijmen more than expected).

Fields of papers citing papers by Bas van Vlijmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas van Vlijmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas van Vlijmen. The network helps show where Bas van Vlijmen may publish in the future.

Co-authorship network of co-authors of Bas van Vlijmen

This figure shows the co-authorship network connecting the top 25 collaborators of Bas van Vlijmen. A scholar is included among the top collaborators of Bas van Vlijmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas van Vlijmen. Bas van Vlijmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bekker, Charlotte L., et al.. (2023). Improvement, Implementation, and Evaluation of the CMyLife Digital Care Platform: Participatory Action Research Approach. Journal of Medical Internet Research. 25. e45259–e45259. 2 indexed citations
2.
Smit, Yolba, et al.. (2023). Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial. BMC Health Services Research. 23(1). 228–228. 5 indexed citations
3.
Bemt, Bart J. F. van den, Eibert R. Heerdink, Ingrid M.E. Desar, et al.. (2023). Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs. JAMA Oncology. 10(1). 87–87. 16 indexed citations
4.
Kraaijpoel, Noémie, Frits I. Mulder, Marc Carrier, et al.. (2023). OC 46.1 Absolute Quantitative Proteomics for Occult Cancer Screening in Patient with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study. Research and Practice in Thrombosis and Haemostasis. 7. 100597–100597. 1 indexed citations
5.
Vlijmen, Bas van, et al.. (2023). Feasibility of an Individualized Dispensing Program for Patients Prescribed Oral Anticancer Drugs to Prevent Waste. JCO Oncology Practice. 19(4). e618–e629. 4 indexed citations
6.
Leeuwen, Roelof W. F. van, Anna K.L. Reyners, Bas van Vlijmen, et al.. (2022). Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management. Seminars in Oncology. 49(2). 119–129. 15 indexed citations
7.
Koornstra, Rutger H.T., Johanna H. M. Driessen, Bas van Vlijmen, et al.. (2018). The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study. Targeted Oncology. 13(3). 363–370. 4 indexed citations
8.
Vlijmen, Bas van, Hans Groenewoud, Gert Jan van der Wilt, et al.. (2018). Individual N-of-1 Trial Salbutamol Versus Placebo as Attack Treatment in a Patient with Hyperkalemic Periodic Paralysis (P3.455). Neurology. 90(15_supplement). 1 indexed citations
9.
10.
Vervloet, Marcia, et al.. (2012). SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. International Journal of Medical Informatics. 81(9). 594–604. 171 indexed citations
11.
12.
Vervloet, Marcia, et al.. (2010). Een oplettend medicijndoosje voor diabetes type 2 patiënten: een onderzoek naar de effecten van Real-Time Medication Monitoring.. Data Archiving and Networked Services (DANS). 2 indexed citations
13.
Vlijmen, Bas van, et al.. (1998). Replacement Policies fro traffic control signals. IMA Journal of Management Mathematics. 9(4). 325–346. 6 indexed citations
14.
Maagdenberg, Arn M. J. M. van den, Marten H. Hofker, Paul Krimpenfort, et al.. (1993). Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. Journal of Biological Chemistry. 268(14). 10540–10545. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Anne Newman-Casey Breakdown of academic impact, for papers by Karen Van Nuys Breakdown of academic impact, for papers by Shahnaz Khan Breakdown of academic impact, for papers by Chanhyun Park Breakdown of academic impact, for papers by So Jung Yang Breakdown of academic impact, for papers by Bobby L. Clark Breakdown of academic impact, for papers by Hua Feng Breakdown of academic impact, for papers by Paul E. Knudson Breakdown of academic impact, for papers by Lonneke Timmers Breakdown of academic impact, for papers by Eleanor Rivera
Rankless by CCL
2026